Sherman Oaks, CA, United States of America

Owen O Witto

This inventor holds 1 USPTO granted patent. Top assignee: Cetus Corporation. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Owen O Witto: Innovator in Chimeric mRNA Detection Methods

Introduction

Owen O Witto is a notable inventor based in Sherman Oaks, CA (US). He has made significant contributions to the field of molecular biology, particularly in the detection of chimeric messenger RNA (mRNA). His innovative work has implications for cancer research and diagnostics.

Latest Patents

Owen O Witto holds a patent for "Chimeric messenger RNA detection methods." This invention provides highly sensitive methods for detecting specific sequences contained in chimeric mRNA. The mRNA sequences are reverse transcribed into complementary DNA (cDNA), amplified by the Polymerase Chain Reaction, and detected by hybridization with a labeled sequence-specific oligonucleotide probe. This method is particularly valuable for detecting chimeric mRNAs expressed by activated oncogenes that result from aberrant genetic rearrangements such as chromosomal translocations. He has 1 patent to his name.

Career Highlights

Owen O Witto has worked at Cetus Corporation, where he has been able to apply his expertise in molecular biology to develop groundbreaking detection methods. His work has contributed to advancements in understanding genetic alterations associated with cancer.

Collaborations

Owen has collaborated with esteemed colleagues such as Ernest S Kawasaki and Francis P McCormick. These collaborations have further enriched his research and development efforts in the field.

Conclusion

Owen O Witto's contributions to chimeric mRNA detection methods highlight his innovative spirit and dedication to advancing molecular biology. His work continues to impact cancer research and diagnostics significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…